Financhill
Sell
19

DOC Quote, Financials, Valuation and Earnings

Last price:
$15.78
Seasonality move :
0.92%
Day range:
$15.71 - $16.00
52-week range:
$15.71 - $21.28
Dividend yield:
7.73%
P/E ratio:
79.93x
P/S ratio:
3.93x
P/B ratio:
1.44x
Volume:
8.9M
Avg. volume:
7.1M
1-year change:
-21.8%
Market cap:
$11B
Revenue:
$2.7B
EPS (TTM):
-$0.06

DOC Analysts' Consensus Rating

The 16 analysts providing 12-month price projections for Healthpeak Properties, Inc. shares anticipate an average target of $20.58, ranging from a low estimate of $17.00 to a high estimate of $29.00. This average target implies a growth of 30.44% compared to the current stock price of $15.78.

Consensus Price Target

$20.58

Highest Price Target

$29.00

Lowest Price Target

$17.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 10 9 8

Hold 5 7 8

Sell 0 0 0
Consensus Buy Buy Leans Bullish

DOC Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.

Buy
54
UNF alert for Dec 23

UniFirst Corp. [UNF] is up 0.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock